TERACHEM 2026
September 23-26, 2026 | Bressanone (BZ), Italy
The fifth edition of the International Symposium on Technetium and Other Radiometals in Chemistry and Medicine (TERACHEM 2026) took place September 23–26, 2026, at the Forum Brixen/Bressanone in Bressanone, Italy, with the support of the Society of Radiopharmaceutical Sciences (SRS). The meeting continued the long-standing tradition of the previous symposia on Technetium and Rhenium in Chemistry and Nuclear Medicine, focusing on recent advances in radiometal coordination chemistry and the latest applications of radiometal-containing molecules in pre-clinical and clinical imaging and radiotherapy.
The Symposium featured keynote lectures and presentations covering the development of medically relevant radiometals and their application in chemistry, radiopharmacy, and nuclear medicine. The detailed program and presentation abstracts remain available online.
Scientific Sessions:
Radionuclide Production & Targetry
Chemistry of Technetium, Rhenium and Other Radiometals in Medicine
Chemistry of Other Radiometals & Ligand Design
Preclinical Development of Metal-Based Radiopharmaceuticals & Radiopharmacology
Translational Radiotherapy and Radiotheragnostics
Radiopharmaceuticals Labeled with Technetium-99m and Other Radiometals
AI in Radiochemistry
Keynote Speakers:
Dr. Ulli Köster, Institut Laue-Langevin (ILL) & Université Grenoble Alpes
Prof. Peter J. H. Scott, University of Michigan
Dr. Michael K. Schultz, Perspective Therapeutics & University of Iowa
Highlights:
Keynote lectures, oral communications, and poster sessions
An Award Presentation Session
Travel bursaries awarded to students and postdoctoral fellows
A social trip and dinner at 1,820 meters above sea level, reached by cable car
Pre-Symposium Summer School:
Leading up to the Symposium, an intensive summer school for students and postdoctoral fellows was held at the Accademia Cusanus in Bressanone, organized by the University of Padova together with the SRS and TERACHEM 2026. Under the theme “Innovating Cancer Care: Next-Gen Theranostic Radiopharmaceuticals from Lab to Clinic for Best Investigational Practices,” participants combined expert-led lectures, interactive workshops, and a project-based exercise following a novel radiopharmaceutical from initial design through preclinical evaluation to potential clinical application.
ACKNOWLEDGEMENTS FOR PROVIDING STUDENT TRAVEL BURSARIES
Symposium Committee:
C.S. Cutler (USA)
R. Schibli (Switzerland)
M.C. Giron (Italy)
U. Mazzi (Italy)
R. Rossin (Italy)
As in previous editions, the Symposium was held in the charming town of Bressanone (BZ), nestled in northern Italy between Lake Garda and the Austrian border, where its welcoming, informal atmosphere allowed young scientists and students to engage in meaningful discussions with experts in the field.
We sincerely thank our corporate partners for their generous support, including our Platinum Sponsor, Comecer, our Gold Sponsor, Ratio, and all of our Silver Sponsors, Sponsors, and local producers, as well as our institutional partners.
Thank you to everyone who attended, presented, and reviewed abstracts at TERACHEM 2026!
UNDER THE AUSPICES OF INSTITUTIONAL PARTNERS
